Established 1999
123jump.com - U.S. Financial Information Archive: 90,000 Annual and 10-K reports – 20,000 Global news stories - 3,500 IPO reports - 1,700 - Earnings Calls – 320 Fund Interviews – 10-year Annual earnings on 4,500 stocks – 20 Quarterly earnings on 3,600 stocks – 1,800 IPO prospectuses – 1,200 Economic data releases
     
   
 

GenVec, Inc.(GNVC)

 
123Jump Rating: - Avoid   Underwriters: J. P. Morgan & Co.
      A.G. Edwards & Sons Inc.
Status: Priced   UBS Warburg LLC
 
Address: 65 W. Watkins Mill Rd.
 FiledDate: 10/05/2000
  Gaithersburg,
    
  MD 20878
 Filed Price Range ($): $11.00-12.00
       
Telephone: 240-632-0740 Filed Offer Amount ($ Million): $38.00
       
Fax: 240-632-0735 Shares Offered (Millions): 4
       
Websites: www.genvec.com Shares Outstanding (Millions): 17.89
       
Management: Thomas Fraser, Chair.
 IPO Date: 12/11/2000
  Paul Fischer, Pres./CEO/Dir.
    
  Douglas Swirsky, CFO
 Final Offer Price ($): $10.00
       
Industry: Biotech Final Offer Size (Millions of Shares): 4.00
       
Employees: 109 Final Offer Amount ($ Million): $40.00
       
Competitors: Alcon
 S-1 Forms:
  Genentech
    
  Schering-Plough
  
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Company Links
Investor Relations Corporate / History Profile Executives Products Services
Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
1995 1005 9318 -8313 0.00 -7900 -9.39
1996 698.37 9811 -9113 0.00 -8617 -7.16
1997 5687.5 12116 -6428.52 0.00 -6165.55 -4.3
1998 9750 16495 -6745.21 0.00 -6347.07 -4.1
1999 16949.94 19446 -2496.38 0.00 -1919.49 -1.22
2000 11339.95 16370.07 -5030.11 0.00 -4657.28 -2.52
*Nine Months ended September 30, 2000
 
 
© 1999-2008 123jump.com. All rights reserved